{
    "title": "105_hr1398",
    "content": "The \"Parkinson's Research Act of 1997\" aims to expand federal investment in Parkinson's research and improve coordination among NIH institutes. It also focuses on enhancing care for individuals with Parkinson's and their caregivers. The \"Parkinson's Research Act of 1997\" directs the Director of NIH to establish a program for Parkinson's disease research and training, coordinating with national research institutes and holding research planning conferences. Additionally, Core Center Grants are awarded to promote innovative research. The Director of NIH shall award Core Center Grants to encourage innovative multidisciplinary research and training on Parkinson's disease. Up to 10 grants will be awarded, designating each center as a Morris K. Udall Center for Research on Parkinson's Disease. Centers must meet specific qualifications and conduct both basic and clinical research on Parkinson's. The Director of NIH awards Core Center Grants to institutions for Parkinson's disease research. Centers must meet qualifications, conduct basic and clinical research, and may offer training programs, education, and data systems. The NIH awards Core Center Grants for Parkinson's disease research, which includes establishing a nationwide data system, an Information Clearinghouse, and a national education program. Centers may also provide stipends for training programs. The NIH awards Core Center Grants for Parkinson's disease research to establish a national education program and provide stipends for training programs. Additionally, the Director of NIH will establish a grant program to support investigators with a proven record of excellence and innovation in Parkinson's Disease research. The Director of NIH shall establish a grant program to support investigators with excellence in Parkinson's research for up to 5 years. $100,000,000 is authorized for fiscal year 1998, with additional funding for 1999 and 2000. No funds under this Act may be used for research involving human fetal tissue from embryos or fetuses. The Act authorizes $100,000,000 for fiscal year 1998, with additional funding for fiscal years 1999 and 2000. No funds can be used for research involving human fetal tissue from embryos or fetuses, except in cases of spontaneous abortion or ectopic pregnancy."
}